Lykka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug
Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of ...
health.economictimes.indiatimes20h
Nerve Fresh Reviews: Does It Really Help Eliminate Neuropathic Pain?
Nerve Fresh is a nerve support supplement developed to help reduce neuropathic pain and promote a healthy nervous system.
Nerve Recovery Max or Nerve Fresh: Which One May Work Best for Real Results?
Affiliate content. Compare Nerve Recovery and Nerve Fresh to find out which supplement is the better choice for nerve health.
Hosted on MSN5d
Nerve Fresh: I Tried It—Here's My Nerve Fresh After 112 Days!
Nerve Fresh entered my life at a time when I was desperate for relief from the relentless tingling and numbness in my f ...
Symptoms of vitamin B12 deficiency in men over 50: Leg pain, cold feet, RLS are warning signs
Vitamin B12 is vital for men in their 50s, supporting brain, nerve, and heart health. Deficiency may cause numbness, balance ...
WebMD4d
The Deadly Diabetes Risk You Don’t Know About
If you’re living with diabetes, learn why you may be at greater risk for opioid use (and misuse) and what to do about it.
The Financial Express4d
Alkem Labs enters into licensing agreement with Sonnet BioTherapeutics for its diabetic peripheral neuropathy drug in India
India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...
Daily3d
Alkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for diabetic peripheral neuropathy in India
Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...
Combining Regenerative Neurotherapy with Traditional Treatments: A Synergistic Approach to Neuropathy
Peripheral neuropathy, a condition affecting millions of people worldwide, can cause chronic pain, numbness, and weakness, ...
Alkem Labs signs licensing agreement with Sonnet BioTherapeutics
Alkem Laboratories said that it has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, to develop, manufacture and commercialise the drug candidate 'SON-080' for the ...